Navigation Links
Quest Diagnostics Declares Quarterly Cash Dividend
Date:2/28/2012

MADISON, N.J., Feb. 28, 2012 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its Board of Directors declared a quarterly cash dividend of $0.17 per share, payable on April 17, 2012, to shareholders of record of Quest Diagnostics common stock on April 3, 2012.

About Quest Diagnostics
Quest Diagnostics is the world's leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative new diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at QuestDiagnostics.com. Follow us at Facebook.com/QuestDiagnostics and Twitter.com/QuestDX.

Quest Diagnostics Contacts:
Kathleen Valentine (Investors): 973-520-2900
Wendy Bost (Media): 973-520-2800


'/>"/>
SOURCE Quest Diagnostics Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Quest Diagnostics to Speak at the 2012 RBC Capital Markets Healthcare Conference
2. Care360® EHR From Quest Diagnostics Honored by Black Books 2012 Rankings and Capterras Top 20 List
3. Quest Diagnostics Offers Industry-First 30-Day Ambulatory EHR Implementation Guarantee for Hospitals and IDNs
4. Questcor Recognized by Child Neurology Foundation for Outstanding Corporate Responsibility and Leadership
5. Amsterdam Molecular Therapeutics Receives Request for Further Information From CHMP on Glybera®
6. Questcor Pharmaceuticals Appoints Scott M. Whitcup, M.D., to Board of Directors
7. NPC Conference to Address Questions on Ability to Share Health Research Findings
8. Amsterdam Molecular Therapeutics Announces European Commission Delays Decision on Glybera® Marketing Authorisation and Requests Further Information From the CHMP
9. Questcor Pharmaceuticals Responds to Questions From Investor Blog
10. Questcor Pharmaceuticals Issues Statement
11. Hologic Announces Denial of Conceptus Request for Injunction in Patent Infringement Suit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/13/2017)... January 13, 2017 This morning, ... how they have fared at yesterday,s closing bell: Clovis ... Inc. (NASDAQ: GALE ), and ACADIA Pharmaceuticals ... cellular and biomolecular processes to develop technologies and products ... footprint, feed the hungry, use less and cleaner energy, ...
(Date:1/13/2017)... , Jan. 13, 2017  Secretary of Health ... professors, and community members at Misericordia University and discussed ... in Pennsylvania . "The ... seen so far in my professional career," Secretary Murphy ... has been hit hard by heroin and prescription opioid ...
(Date:1/13/2017)... -- Research and Markets has announced the addition of ... to their offering. ... Cystic fibrosis (CF) is a progressive genetic condition and is ... conductance regulator (CFTR) gene from both parents. The defective CFTR genes ... in the buildup of a thick and sticky mucus in the ...
Breaking Medicine Technology:
(Date:1/16/2017)... (PRWEB) , ... January 16, 2017 , ... NexTec Group ... a group of 100 organizations honored for their accomplishments in the field of midmarket ... growth, industry leadership and recognition, and innovation. Selection is not based on revenue and ...
(Date:1/15/2017)... ... January 15, 2017 , ... "On Tour is a music themed slideshow ... ease," said Christina Austin - CEO of Pixel Film Studios. , On Tour’s ... the style and animation of their slideshows. Place each slide on top of another ...
(Date:1/14/2017)... ... January 14, 2017 , ... Healthy living brand Moody Zook ... charcoal products. With more and more people opting to go organic in their ... they cater to specific needs. , Moody Zook focused particularly on their newly ...
(Date:1/13/2017)... ... January 13, 2017 , ... The 18th European Congress: Perspectives in Lung Cancer ... 2017. This Congress is expertly designed to meet the educational needs of European ... cancer. , Chaired by Dr. Giorgio V. Scagliotti, Professor of Oncology at the University ...
(Date:1/13/2017)... ... January 13, 2017 , ... An inventor from Virginia Beach, Va., is ... in order to diversify my outfits, so he decided to design something that enhances ... enhances the appearance of a belt to allow for quick, easy changing of its ...
Breaking Medicine News(10 mins):